Can Hu

2.0k total citations · 1 hit paper
31 papers, 1.6k citations indexed

About

Can Hu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Can Hu has authored 31 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Cardiology and Cardiovascular Medicine and 11 papers in Physiology. Recurrent topics in Can Hu's work include Adipose Tissue and Metabolism (10 papers), Chemotherapy-induced cardiotoxicity and mitigation (6 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). Can Hu is often cited by papers focused on Adipose Tissue and Metabolism (10 papers), Chemotherapy-induced cardiotoxicity and mitigation (6 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). Can Hu collaborates with scholars based in China. Can Hu's co-authors include Zhen‐Guo Ma, Xin Zhang, Qizhu Tang, Hai‐Ming Wu, Yu‐Pei Yuan, Chun‐Yan Kong, Wenying Wei, Si‐Chi Xu, Lingli Li and Wei Deng and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Can Hu

31 papers receiving 1.6k citations

Hit Papers

FNDC5 alleviates oxidative stress and cardiomyocyte apopt... 2019 2026 2021 2023 2019 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT
    2019 359 citations Xin Zhang, Can Hu et al. Cell Death and Differentiation profile →

Peers

Can Hu
Chun‐Yan Kong China
Si‐Chi Xu China
Qi‐Zhu Tang China
Junlian Gu China
Yu‐Pei Yuan China
Xiaoyan Qi China
Miranda M. Sung Canada
Michinari Nakamura United States
Chun‐Yan Kong China
Can Hu
Citations per year, relative to Can Hu Can Hu (= 1×) peers Chun‐Yan Kong

Countries citing papers authored by Can Hu

Since Specialization
Citations

This map shows the geographic impact of Can Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Hu more than expected).

Fields of papers citing papers by Can Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Can Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Hu. The network helps show where Can Hu may publish in the future.

Co-authorship network of co-authors of Can Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Can Hu. A scholar is included among the top collaborators of Can Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Can Hu. Can Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xin, et al.. (2025). FNDC4 Prevents Aging-Related Cardiac Dysfunction. JACC Basic to Translational Science. 10(7). 101222–101222. 1 indexed citations
2.
Wu, Song, Tianyao Wang, Can Hu, et al.. (2025). Microstructure changes of the brain preceded glymphatic function changes in young obesity with and without food addiction. SHILAP Revista de lepidopterología. 3(1). 100137–100137. 1 indexed citations
3.
Hu, Can, et al.. (2025). A brief overview of the E3 ubiquitin ligase: TRIM7. Cellular Signalling. 134. 111886–111886. 1 indexed citations
4.
Dong, Wen‐Sheng, Can Hu, Min Hu, et al.. (2024). Metrnl: a promising biomarker and therapeutic target for cardiovascular and metabolic diseases. Cell Communication and Signaling. 22(1). 389–389. 12 indexed citations
5.
6.
Hu, Can, et al.. (2024). CREB3 protein family: the promising therapeutic targets for cardiovascular and metabolic diseases. Cell Biology and Toxicology. 40(1). 103–103. 2 indexed citations
7.
Zhang, Xin, Can Hu, Zhen‐Guo Ma, et al.. (2023). Tisp40 prevents cardiac ischemia/reperfusion injury through the hexosamine biosynthetic pathway in male mice. Nature Communications. 14(1). 3383–3383. 44 indexed citations
8.
Hu, Min, Xin Zhang, Can Hu, Teng Teng, & Qi‐Zhu Tang. (2022). A brief overview about the adipokine: Isthmin-1. Frontiers in Cardiovascular Medicine. 9. 939757–939757. 14 indexed citations
9.
Teng, Teng, Chun‐Yan Kong, Rong Huang, et al.. (2022). Mapping current research and identifying hotspots of ferroptosis in cardiovascular diseases. Frontiers in Cardiovascular Medicine. 9. 1046377–1046377. 7 indexed citations
10.
Zhang, Xin, Can Hu, Yu‐Pei Yuan, et al.. (2021). Endothelial ERG alleviates cardiac fibrosis via blocking endothelin-1-dependent paracrine mechanism. Cell Biology and Toxicology. 37(6). 873–890. 69 indexed citations
11.
Zhang, Xin, Can Hu, Ning Zhang, et al.. (2020). Matrine attenuates pathological cardiac fibrosis via RPS5/p38 in mice. Acta Pharmacologica Sinica. 42(4). 573–584. 98 indexed citations
12.
Hu, Can, Xin Zhang, Peng Song, et al.. (2020). Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP/PKA/SIRT1 pathway. Redox Biology. 37. 101747–101747. 181 indexed citations
13.
Li, Lingli, Wei Li, Ning Zhang, et al.. (2020). Levosimendan Protects against Doxorubicin‐Induced Cardiotoxicity by Regulating the PTEN/Akt Pathway. BioMed Research International. 2020(1). 8593617–8593617. 18 indexed citations
14.
Zhang, Xin, Can Hu, Hai‐Ming Wu, Zhen‐Guo Ma, & Qi‐Zhu Tang. (2020). Fibronectin type III domain-containing 5 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target. Acta Pharmacologica Sinica. 42(9). 1390–1400. 23 indexed citations
15.
Zhang, Xin, Can Hu, Chun‐Yan Kong, et al.. (2019). FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT. Cell Death and Differentiation. 27(2). 540–555. 359 indexed citations breakdown →
16.
Hu, Can, Xin Zhang, Wenying Wei, et al.. (2019). Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via maintaining AMPKα/UCP2 pathway. Acta Pharmaceutica Sinica B. 9(4). 690–701. 217 indexed citations
17.
Hu, Can & Qi‐Zhu Tang. (2018). GW29-e1485 Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity. Journal of the American College of Cardiology. 72(16). C44–C45. 1 indexed citations
18.
Zeng, Dan, Can Hu, Ru‐Liu Li, et al.. (2018). Polysaccharide extracts of Astragalus membranaceus and Atractylodes macrocephala promote intestinal epithelial cell migration by activating the polyamine-mediated K+ channel. Chinese Journal of Natural Medicines. 16(9). 674–682. 17 indexed citations
19.
Zhang, Ning, Wenying Wei, Hai‐Han Liao, et al.. (2018). AdipoRon, an adiponectin receptor agonist, attenuates cardiac remodeling induced by pressure overload. Journal of Molecular Medicine. 96(12). 1345–1357. 39 indexed citations
20.
Zhang, Ning, Wenying Wei, Lingli Li, Can Hu, & Qizhu Tang. (2018). Therapeutic Potential of Polyphenols in Cardiac Fibrosis. Frontiers in Pharmacology. 9. 122–122. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chun‐Yan Kong Breakdown of academic impact, for papers by Si‐Chi Xu Breakdown of academic impact, for papers by Qi‐Zhu Tang Breakdown of academic impact, for papers by Junlian Gu Breakdown of academic impact, for papers by Yu‐Pei Yuan Breakdown of academic impact, for papers by Xiaoyan Qi Breakdown of academic impact, for papers by Miranda M. Sung Breakdown of academic impact, for papers by Michinari Nakamura
Rankless by CCL
2026